Related by context. All words. (Click for frequent words.) 48 BSHSI 48 C#/C#ISR 48 ACRIN 48 · Coordinate 47 ICAEL 47 Dyadem Stature 46 www.sanbolic.com 46 Actively participates 46 DGGS 46 tables summarize 46 Mtsare Khevi Field 45 Vaxfectin R 45 SemGroup LP SemGroup 45 prospective observational studies 45 Plan Disclosure Document 45 CCDF 45 MYTHOS trial 45 Biomerk Tumorgrafts 45 TruExposure 45 Expect flyspeck scrutiny 45 fund BioSante LibiGel 44 Vaxfectin TM 44 Exelixis XL# 44 Asthma Intervention 44 HCAHPS survey 44 biostatistical analysis 44 LAE reserves 44 ENDEAVOR clinical 44 Investigator Initiated 44 SS NOI helps 44 observational cohort 44 PCWP 44 Proficy Change 44 MBCx 44 Asset Management IAM 44 preclinical studies Vion 44 GPNMB expression 43 Dialysis Outcomes 43 biowarfare detection 43 NADiA 43 WREP 43 BioSante LibiGel Phase III 43 CSF Assurance 43 TransVax tm 43 CATIE AD 43 CIMIP 43 tolerability pharmacokinetics 43 Acute MI 43 METAspectrum evaluation provides 43 NLASCO 43 antiviral stockpiling 43 DataDrill 43 Medworxx UMS 43 PRESEPT 43 HDL Selective Delipidation 43 Summex 43 please visit http:/www.weingarten.com 43 SUTIMCo 43 TAXUS VI 43 sapacitabine CYC# 43 realizability 43 PD2i ® algorithm 43 RIGScan CR 43 Roland Weichert 43 Carticept 43 Contingent Workforce Management 43 By RUSH WOOD 43 REACH Registry 42 RTO RPO 42 RiskResolve 42 Generally Accepted Accounting Principle 42 WEICan 42 regarding AngelCiti 42 contingent guaranties 42 cardiometabolic syndrome 42 REALITY Trial 42 situ extraction 42 accurately visualize simulate 42 Levulan ® PDT 42 NMR LipoProfile test 42 APEX AMI 42 underlying sulfide mineralization 42 FirstGateways 42 IFRS changeover 42 Phase IIb III 42 pharmacodynamic PD 42 KRIs 42 adopting IFRS 42 CATRADER 42 NAIC RBC 42 Equitable Midstream 42 possible responses Goshko 42 Multivariate logistic regression 42 STRIDE PD 42 LinuxLink reduces 42 EACM 42 MGCD# clinical trials 42 balance sheet deleveraging 42 Vindicator LWS 42 microsimulation model 42 HIV RDEA# 42 APPRAISE 42 compensatory mitigation 42 RiskLink 42 Urix 42 Western Airborne Contaminants 42 Matrikon TM 42 Spokeswoman Emily Langlie 42 HORIZONS AMI trial 42 Ovarian Cancer Screening 42 NewNorth Projects Ltd. 42 FGDC 42 Jesse Blout San Francisco 42 BARI 2D 42 empirically validated 42 NICE SUGAR 42 FinancialAnalytics 42 upon Trevali metallurgical 42 ABPP 41 Meta analyzes 41 GCom 41 WME ranking 41 Outcome Measures 41 withrespect 41 QHSR 41 Styrene butadiene rubber 41 BACcel 41 Orion NCM 41 MERLIN TIMI 41 iv unanticipated 41 PreDx DRS 41 Pharmacodynamic 41 andmanagement 41 Briggs discusses NCCAM 41 metocean 41 BMC ProactiveNet Performance 41 QAQC protocol 41 PARTNER Trial 41 Medmarc 41 MoxDuo TM IR 41 nitrogen oxides particulate matter 41 CaPSURE 41 Ovarian PLCO Cancer 41 #CL# 41 MCDH 41 metallurgical flowsheet 41 neratinib 41 Corprasoft Legal Desktop 41 CRMD# 41 bioleach 41 ONTARGET 41 REVIVE Diabetes 41 ratio ICER 41 Aspiration Software 41 Lung Injury 41 Alter Nrg 41 Shigamabs 41 diagnostic prognostic 41 WGSI 41 Verint Systems Inc 41 results Martin Kotthaus 41 eTag assays 41 website www.bancroftfund.com 41 Firecreek Petroleum 41 Dalrada Financial 41 ACS NSQIP 41 Trofex 41 IntegriGuard 41 PDX pralatrexate 40 PRECISE Trial 40 MassCEC 40 Ivara 40 By DEE DIXON 40 National Oncologic PET 40 StockMarks framework 40 Pre RELAX AHF 40 Manaris 40 xxxi adverse tax 40 CHAMPION PCI 40 Zevalin consolidation 40 FEDMFC 40 postmenopausal osteoporotic women 40 pharmacodynamic markers 40 ongoing Phase IIIb 40 prelicensure 40 LibiGel NDA 40 Proved undeveloped reserves 40 Kemetco 40 strategic reallocations 40 Group RTOG 40 SVSP 40 dbGaP 40 Prostate Cancer Outcomes 40 Medicalis 40 condensate stripping 40 mg BID dose 40 StatementOne 40 CPMRC 40 Backup Accelerator 40 Storie molybdenum 40 whitepaper explores 40 PowerPC #GT 40 DEcIDE 40 MSCRAMM 40 Anticipation Advantage 40 enzyme immunoassay EIA 40 vi ineffectiveness 40 MuniFinancial 40 Verisk Health 40 MEND CABG 40 SPEC MPI# 40 VIRTERA 40 Valyd 40 BCIRG 40 Biophysical# 40 liquidate REO 40 MEND CABG II 40 deCODE AF TM 40 TobacAlert TM tests 40 Visit www.transre.com 40 LibiGel Phase III 40 taribavirin 40 Prefeasibility Study 40 TRA 2P 40 pharmacodynamic parameters 40 Trofex ™ 40 Odesia 40 RealTime Performance 40 AVI RNA based 40 LUMINATE 40 pegylated interferon alfa 2b 40 Benefit Informatics 40 Corporation NASDAQ FADV 40 HF ACTION 40 repeatable defensible 40 Tockwotton 40 SolutionsPath 40 CPPW 40 SYSTEMSgroup Protective Services 40 Primawave 40 Anceta 40 ResponseDX Lung TM 40 Suroco 40 NATRECOR R 40 HP WebInspect 40 Flow cytometry 40 Oxide Project 40 Primary Care Providers 39 ProLogis Kingspark 39 Affymetrix microarray technology 39 Pharmacokinetic parameters 39 DF HCC 39 National Inpatient Sample 39 Company noncontributory defined 39 ExTRACT TIMI 39 Dynegy cautions 39 purinergic receptors P#X# 39 GAMMAGARD 39 GHG mitigation 39 CARE HF 39 Halozyme Ultrafast Insulin 39 Donkin Coal 39 Walt Rakowich 39 Tyrone Jue 39 stage Serrote Deposit 39 Shape HF 39 ROI calculator 39 ACUITY trial 39 FLG Partners 39 ZYBRESTAT fosbretabulin 39 COPIC 39 Vertebral Fracture 39 Intervention Effectiveness 39 NCCTG N# 39 Prostate Disease 39 CardioPET 39 NOPR 39 NCQA accreditation 39 Waterflood 39 dfPower Studio 39 xxxiii 39 IMRAN Press 39 Still Wootan 39 rating nonsignificant 39 AIM HIGH 39 resultsof 39 Synertech 39 prospective multicentre 39 SMRI 39 Multicenter Automatic Defibrillator Implantation 39 mainframe midrange 39 TRILOGY ACS 39 wetland delineations 39 ValuEngine Rating 39 Computed Tomographic 39 DxCG 39 Dokie Wind 39 OpenView Labs 39 Heart Transplant Recipients 39 HispanTelligence ® 39 ritonavir boosted danoprevir 39 OBJECTIVES 39 estuarine habitats 39 optimally allocate 39 Brucejack Area 39 amortization EBITDA adjusted EBITDA 39 WikiWealth.com s 39 Cervical Cytology 39 adjuvant GIST 39 RES PowerFuse 39 coding debugging 39 hypoxia selective 39 PREVU x LT 39 Neuradiab 39 bioFILM PA TM 39 NSQIP 39 merchant chargebacks 39 ASSERT 39 ARID tool 39 Alpha Tocopherol Beta Carotene 39 p# biomarker 39 Cornea Donor Study 39 proprietary MSCRAMM protein 39 FullCircle 39 MGN# 39 Chepica 39 caustic fusion diamond 39 BioImage Study 39 ATOLL 39 TARP CPP 39 differential gene expression 39 vFoglight Pro 39 SUCCEED trial 39 NAEY 39 commission Safwat Rashid 39 XP# XP# 39 CANMET MTL 39 GHG emission reduction 39 DELISTING REVIEW 39 EcaFlo 39 Randomized Evaluation 39 existing wellbores 39 pharmacokinetics pharmacodynamics 39 IMCD TM 39 engineered nanoscale 39 CQI 38 SCIT 38 OLYMPIA registry 38 FERC relicensing 38 Frasergold Project 38 Claimetrics 38 pharmacodynamic effects 38 exploratory endpoints 38 Acute Coronary Syndromes 38 contiguous acreage 38 Cancer Genetic Markers 38 GlobalTrak TM 38 co receptor tropism 38 TAXUS V 38 oncologic outcomes 38 GBAC 38 assaying protocols 38 spokeswoman Marna Daley 38 Vasogen Celacade 38 VCORE 38 ORE# 38 sulfur dioxide SOx 38 software visit http:/www.borland.com 38 randomizing patients 38 nutrient leaching 38 molecular chaperone regulation 38 Calmare pain 38 Augment Injectable 38 Dataflow Manager 38 BLA filing 38 ENRICH trial 38 OSAM 38 EcaFlo TM 38 NextPage Document Retention 38 Equinix excludes 38 TVCS 38 antithrombotic therapy 38 value Amiworld continuously 38 comparative genomic 38 RMHP 38 Canariaco Norte copper 38 Xphase principals 38 tolerability profiles 38 MagEnergy 38 Trial PCPT 38 www.dovercorporation.com 38 analy sis 38 file INDs 38 prospective randomized multicenter 38 NESARC 38 DCTS 38 Women Ischemia Syndrome 38 CINQUIL 38 HigherEd Analytics 38 Coro Mining 38 Shepell fgi 38 wildland arson 38 Syllego system 38 xi unanticipated 38 chemokine receptor CCR1 38 Polyethylene terephthalate 38 NP2 Enkephalin 38 Toromocho Project 38 eValue8 38 placebo controlled multicenter 38 · Demonstrated 38 procyclical effects 38 Innovative Geospatial 38 anduncertainties 38 CBRN detection 38 FRBA 38 venous thromboembolic disease 38 VerifyNow P#Y# 38 ZEVALIN therapeutic regimen 38 CAPRIE 38 soil carbon sequestration 38 Massachusetts Estuaries Project 38 geotechnical investigations 38 synthetic lethality 38 toreduce 38 Phynance 38 Our PMVS 38 Computer Assisted Retinal 38 QOPI 38 examines Chinas 38 pharmacoeconomic analysis 38 WESST Corp 38 Phase IIb clinical trials 38 Six Sigma Lean 38 Senior Secured Loan 38 HIV AIDS BC CfE 38 Enzyme Leach 38 STRATEGY FOR AN OPEN 38 RFP RFI 38 multivariate statistical 38 Studies #CL# #CL# #CL# 38 Primary endpoints 38 Oral NKTR 38 human IgG1 monoclonal 38 pilot readback error 38 Zemiva 38 Property Catastrophe Reinsurance 38 safety tolerability pharmacokinetic 38 LLC BMIS 38 CORE K# 38 CGEMS 38 Resuscitation Outcomes Consortium 38 related hematological toxicity 38 PROTECT II 38 Demonstrable experience 38 SWOG 38 Trucost Plc 38 ug dose 38 Anturol TM 38 Cimzia TM 38 Phase #/#a clinical 38 Radiation Therapy Oncology 38 CMMI maturity 38 CAH designation 38 Val HeFT 38 VESTASYNC II trial 38 RMEI works 38 ICP MS AAS 38 prostate carcinogenesis 38 environmentally beneficial 38 contrast echocardiography 37 geological geophysical geochemical 37 Capacity Planner 37 CH2M HILL Managed 37 linear regression analyzes 37 ARCALYST ® rilonacept 37 thetreatment 37 RiverSource Life 37 CJCC 37 posttrial 37 biodiversity wildlife habitat 37 Registry NOPR 37 PERSEUS 37 PK PD modeling 37 MKS Integrity TM 37 carbohydrate polymers 37 whitepaper outlines 37 CIMZIA ™ 37 detecting diagnosing 37 LEVADEX ™ 37 thoracoscopic lobectomy 37 Nektar proprietary 37 ASC MSRC 37 Understand companys 37 Ionizing Radiation 37 ENGAGE AF TIMI 37 Gloria Vanderham 37 Sitrof Technologies 37 SPIVA methodology 37 TADS 37 cryosurgical treatment 37 rPA vaccine candidate 37 Neighbourhoods Alive 37 AZOR 37 NEVO RES 37 ourbusiness 37 Patient Registry 37 detailed SCPT strengths 37 monoclonal antibody biologic 37 potent suppressor 37 pharmacokinetic pharmacodynamic 37 arenot limited 37 Vignette Nasdaq VIGN 37 ANR Pipeline Company 37 BWise enables 37 AppWorx 37 ChromoCure 37 Signature Exploration 37 postdischarge 37 dispositions financings 37 PLCO 37 Cancen Oil Canada 37 CMV vaccine 37 OMS# 37 DFSP 37 Verismic Software 37 Cognitive Aging 37 StreamServe EDP solutions 37 Spreigl evidence 37 EchoCRT 37 Secondary efficacy endpoints 37 Mantel Haenszel 37 Alternative Scenarios 37 Flagstone Suisse 37 pharmacokinetic PK 37 pharmacodynamics PD 37 Bipolar Disorder STEP BD 37 waterborne infectious diseases 37 aplindore 37 Screening Trial DMIST 37 budesonide MMX Phase III 37 mapping geochemical sampling 37 brine inflows 37 MEDai Risk 37 Ecosphere Ozonix technology 37 Aetna PPO 37 licensed timberlands 37 CAEs 37 pain palliation 37 power petrochemical metallurgy 37 Concurrent Everstream line 37 Mitigating factors 37 Greenhill Caliburn 37 workplans 37 semistructured interviews 37 SCENARIOS Possible 37 postmarket safety 37 Gahcho Kué 37 CA9 SCAN 37 NBCR 37 PDE# inhibitors 37 immunotherapeutic approaches 37 mitigative 37 Stratos Genomics 37 Phase Ib Clinical Trial 37 Develop 37 deforolimus 37 implement rigorous QA 37 CALM Shoulder Screen 37 genomic biomarker 37 REgeneration Finance 37 CALEA assessors 37 Edupoint 37 Altarum 37 Allovectin 7 ® 37 National Biosurveillance Integration 37 MCOE 37 opioid bowel dysfunction 37 spokesman Ken Schrad 37 solutionsthat 37 Petit Goave seaside 37 innovative AHP pigment 37 Usable Light 37 Val MARC 37 Encelium 37 TAXUS IV 37 PFO migraine 37 Dr. Fombonne 37 CLARITY TIMI 37 Peyman Mestchian 37 STEDESA 37 · Oversee 37 SmartChip TM product 37 viabilities 37 RI WINs 37 Patuxent Partnership 37 lowering TCO 37 evaluate 37 controlled multicenter 37 Urocortin 2 37 MediGene focuses 37 neural crest stem cell 37 demonstrated clinically meaningful 37 Carotid Revascularization Endarterectomy vs. 37 Govplace 37 Trandolapril 37 Phase III metastatic melanoma 37 Complications Trial 37 SEDAR.com 37 combating transnational organized 36 CALGB 36 PJTG 36 Phase III LibiGel 36 PROactive 36 LPT Agreement 36 Therein lurks 36 corrosivity 36 adaptive reuses 36 clinicopathologic 36 developing ViaCyte SM 36 placebo controlled Phase III 36 Proficiency Testing 36 MedAllies 36 prospective nonrandomized 36 CTTH 36 Canaccord Relief Program 36 Targeted Molecular Diagnostics 36 PowerSouth Energy 36 Xybion 36 Contrast Echocardiography 36 Ms. Chmieleski 36 EOX 36 TQT 36 MMWEC 36 DXMark 36 Combined Entity 36 recombinant plasma 36 J Immunol 36 Prospective Multicenter 36 MDEP 36 ATB Investor 36 NAICO 36 MedGuardian 36 CGDI 36 MCAN 36 CS STARS 36 rhMBL 36 availableto 36 producibility 36 CLX Investments 36 NSABP B 36 Bacterin proprietary 36 Atapco 36 variable annuity guarantees 36 XL GAPS 36 indications contraindications 36 LS Grande 36 Defined Contribution Plan 36 ACCLAIM II 36 Decompensated Heart Failure 36 logistic regression models 36 Hezel Associates 36 periodically reassessed 36 EMDC 36 randomized Phase 2b 36 PROactive study 36 adversely affect Waste Connections 36 Uhhhhh Bosh 36 convergent validity 36 Visit OptionsHouse 36 Agencourt Bioscience 36 Needs Assessments 36 Olameter 36 peripheral vascular diseases 36 injectants 36 SUA Insurance 36 acquisitions divestitures strategic alliances 36 unmeasured confounding 36 prospective observational cohort 36 Michael Matvieshen 36 ProSys 36 Prostate Lung Colorectal 36 Hadyn Butler P.Geo 36 Transmonde 36 Check 36 GroupSystems 36 Patient Outcomes 36 MEI Technologies 36 CRPs 36 JM Dutton adds 36 wetland riparian 36 patients undergoing percutaneous 36 being institutionally averse 36 Platinol ® cisplatin 36 pixel RGB 36 ElderTrust 36 include MedGuardian patient 36 Predictive modeling 36 atherogenic dyslipidemia 36 NWND 36 dhc 36 TranSwitch indebtedness 36 quantitative gene expression 36 Vital Statistics System 36 clinical pharmacology studies 36 Métier 36 generalisability 36 meta regression 36 empiric therapy 36 noninvasive diagnostic 36 HepeX B TM 36 Abiliton 36 Lovell Minnick 36 postconviction counsel 36 Digital Mammographic Imaging 36 survivability enhancements 36 GHG emitting 36 Bonasika Project 36 deterring pirate 36 pharmacogenetic testing 36 GEROVA underwrites insurance 36 CentriServ 36 hydrogeologic 36 metabolomic profiling 36 Nicole Rosmarino WildEarth Guardians 36 methodologic 36 waterflooding 36 Critical Elements 36 Tradar Insight 36 Consolidated Backup VCB 36 intercompany reinsurance 36 IGIC 36 SADD chapters 36 Nephros Therapeutics 36 Albourne Partners 36 malignant mesothelioma Alfacell 36 GridWorks 36 Lycopodium Engineering 36 FileTek 36 Cohort Consortium 36 Healthy Living Academies 36 Advisory Councils RACs 36 IAAO 36 hpSCs avoid ethical 36 UA NSTEMI 36 EMPOWER ™ 36 Renal dysfunction 36 Confirmatory tests 36 Destum Partners 36 Multicenter Phase 36 imprudently invested 36 CEUS 36 RH1 targeted chemotherapeutic agent 36 eFORCE 35 ultimate recoverability 35 tezampanel NGX# 35 Survey MEPS 35 polymetallic zinc 35 safety tolerability pharmacodynamics 35 ZixGateway Inbound 35 PowerCockpit 35 DDoS Detection 35 incyclinide 35 geophysicists geologists 35 TURNS Treatment 35 Aetna Specialty Pharmacy 35 APEX AMI trial 35 Clinical Genomics 35 Gamma Dynacare 35 Canon imageRUNNER MFPs 35 Mechdyne 35 ARIC 35 MTWA testing 35 NASDAQ FLML 35 whitepaper discusses 35 Instructional Specialist 35 Baldrige Criteria 35 Goldpines 35 FinCor Solutions 35 Lamaque property 35 unblind 35 NELS 35 regulatory compliances 35 TPTP 35 endothelin antagonists 35 Echocardiographic 35 AdvisorShares ETFs 35 Ron Klauda Maryland 35 oxypurinol 35 Psychol Med 35 Interagency Registry 35 NATRECOR ® 35 Concur excludes 35 nutrigenomic 35 blackbird baiting 35 oceanwide tsunami 35 lymphatic mapping 35 KICO 35 Protalex 35 NewNorth 35 spokeswoman Trish Nicasio 35 DemandSMART 35 KRAS mutations occur 35 nonpoint source 35 Q#IR 35 c Relates 35 Genilogix 35 Initiative K DOQI 35 proactively manage 35 greehouse gas 35 Canvaxin TM 35 M. Achary 35 Everstream measure 35 DEEP AF 35 psychoeducational 35 FFO Measures 35 appropriately resourced 35 thrombin inhibiting aptamer 35 Landsat imagery 35 Avastin adjuvant 35 Borrower Benefits 35 cedents 35 Headwater Technology 35 AGPA 35 Diabetes Complications 35 angina myocardial infarction 35 LHAND 35 Lp PLA 2 35 LandStar Inc. s 35 much BlueBeat owed 35 includedin 35 Thiro 35 NHDS 35 Magneceutical ® Therapy 35 Internally DTE Energy 35 VETO HB 35 EMPHASIS HF 35 TSX SCP Sprott 35 cariprazine 35 NCHC 35 VeraTag assays 35 Trelys 35 EMPOWER TM 35 Archer Cathro 35 FuelQuest solutions 35 KN excels 35 mitigating 35 BioNumerik 35 Coalspur 35 GERD migraine headaches 35 RMR Advisors Inc. 35 OptiCon R4 35 Pantanillo 35 Lac Rocher 35 QTinno 35 CWCS 35 Haynesville acreage 35 ACCF 35 Data Extraction 35 practices Piszel 35 Jim Rier 35 Ms. Nappier 35 EURIDIS 35 Microbial Genome 35 Normative Aging Study 35 Acute Decompensated Heart Failure 35 Carotid endarterectomy 35 Boomerang massive sulphide 35 AQHI 35 CoPs 35 conditional logistic regression 35 WiROI 35 metaanalysis 35 Hematide ™ peginesatide 35 Geosyntec 35 nonpharmacologic 35 PRIMIS 35 integrate restructurings consolidations 35 transboundary movements 35 Intervention Trial GAIT 35 investigational humanized monoclonal antibody 35 MatchMetrix 35 MEDfx 35 Neuroepidemiology 35 PERFMAN 35 Pay 35 Secondary endpoints include 35 WarrenShepell 35 ESHO 35 topical agent Xantryl 35 ADME properties 35 ragweed allergic 35 multicenter trials 35 suppl #S 35 Stop Hypertension DASH 35 COMBINE Study 35 Ken Godskind chief 35 Acrylamide forms 35 longitudinal observational study 35 ecotoxicological 35 nonpharmaceutical interventions 35 SECOR Consulting 35 CMEEC 35 serum GGT 35 spontaneous preterm delivery 35 VT MAK 35 naronapride 35 tubulin inhibitor 35 apprehending fugitives 35 STERIA 35 stocks Outperform Mkt 35 ARDIS 35 PassMark Software conducted 35 WNS ADS 35 Pandemic Severity Index 35 NCCTG 35 AMERIGROUP Corporation 35 PharMetrics 35 Steering Committees 35 etiologic 35 PhG alpha 1 35 BFPET 35 ionizing irradiation 34 Phase #b/#a 34 laser Doppler 34 barrenwort extraction efficiency 34 CMHCs 34 NBIC 34 toimplement 34 Prosaptide 34 toenhance 34 Travelers Indemnity Co. 34 Pfizer respectfully disagrees 34 HanoverTrade 34 neuropathy sparing 34 flurpiridaz F 34 VimpelCom disclaims 34 IDTF 34 JAMA. 34 System BRFSS 34 LifeVillage 34 deCODE Genetics Illumina Navigenics 34 BSIs 34 Panzem R NCD 34 cardiometabolic 34 efficacy evaluable 34 CEDF 34 Rollcast 34 Multiple Proteases And 34 postoperative ileus POI 34 ediscovery 34 randomized controlled trials RCTs 34 AML CFT regime 34 RE LY ® 34 APTIVUS ritonavir 34 Minimizes 34 KRAS mutation status 34 Co KUFPEC 34 HCHC 34 Corporation JEDCO 34 peptidome 34 SIMPADICO 34 situ leach 34 nonprescription NSAIDs 34 procedures Hockeimer 34 Cloretazine 34 Bayesian statistical 34 Roy Haythorn 34 persistency mortality 34 Salary.com SkillsManager 34 Trial NLST 34 atherothrombotic 34 Confederation Freezers 34 androgen suppression 34 Bobby S. Shackouls 34 preclinical pharmacology 34 endophenotypes 34 KIF6 gene variant 34 evaluating 34 physiological nutritional 34 ETRM solutions 34 hypoxia activated prodrug 34 Arch Intern Med 34 M. Pasquale NHP 34 ISSG 34 Inc. NASDAQ TRMP 34 Inuvialuit Settlement Region 34 CareManager 34 CLIRS trial 34 BancTec offerings include 34 KVC Behavioral HealthCare 34 nitrate leaching 34 includes TOLAMBA TM 34 Medicals Direct 34 D2Hawkeye 34 Vitality Re 34 ORIX Venture Finance 34 CompactSafe TM 34 AI AN